Wednesday, Jun 03, 2020 | Last Update : 04:48 PM IST

70th Day Of Lockdown

Maharashtra72300313332465 Tamil Nadu2458613706200 Delhi221329243556 Gujarat17632118941092 Rajasthan92716267201 Uttar Pradesh83615030222 Madhya Pradesh82835003358 West Bengal61682410364 Bihar3945174123 Andhra Pradesh3791241464 Karnataka3408132852 Telangana2891152692 Jammu and Kashmir260194631 Haryana2356105521 Punjab2301200044 Odisha210412459 Assam14862854 Kerala132760811 Uttarakhand9592225 Jharkhand6612965 Chhatisgarh5481211 Tripura4231730 Himachal Pradesh3401186 Chandigarh2972144 Manipur83110 Puducherry79250 Goa73500 Nagaland4300 Meghalaya28121 Arunachal Pradesh2010 Mizoram110 Sikkim100

Trump praises India for lifting ban on sale of Hydroxycloroquine

THE ASIAN AGE
Published : Apr 8, 2020, 1:08 pm IST
Updated : Apr 8, 2020, 1:08 pm IST

Statement comes a day after he threatened to retaliate against India for banning its export.

File image of US president Donald Trump. (AP)
 File image of US president Donald Trump. (AP)

Washington: In what seems to be a major U-turn, US president Donald Trump on Tuesday praised New Delhi for allowing the sale of Hydroxycloroquine, a key anti-malaria drug that is being used to Covid-19, The Economic Times reported.

Trump's statement comes just a day after he threatened to retaliate against India for banning the export of the drug. In a telephonic interview with Fox News, he was quoted by ET as saying, “I bought millions of doses. More than 29 million. I spoke to PM Modi, a lot of it comes out of India. I asked him if he would release it? He was Great. He was really good. You know they put a stop because they wanted it for India. But there is a lot of good things coming from that."

Trump and Prime Minister Modi had spoken over the phone last week. During the call, Trump had requested Modi to lift the hold on the American order of hydroxychloroquine, of which India is the major producer.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York. Anticipating that it will work, given initial positive results, Trump has bought more than 29 million doses of hydroxychloroquine for potential treatment of COVID-19 patients.

India on Tuesday allowed the export of hydroxychloroquine to the US, which has emerged as the global hotspot of Covid-19.

By Tuesday night, nearly four lakh Americans tested positive for the novel coronavirus and the fatalities was more than 12,850. During the interview, Trump described hydroxychloroquine as a powerful malaria drug. The drug is being tested on hundreds of coronavirus patients in New York.

“But there are a lot of good things coming from that,” Trump said.

“Lot of people are looking at it and saying, you know I don't hear bad stories, I hear good stories. And I don't hear anything where it is causing death,” said the US President.

Hydroxychloroquine, an old and inexpensive drug used to treat malaria, is seen as a viable therapeutic solution by President Trump to coronavirus.

Last week Trump said he has sought help from Prime Minister Modi to allow the sale of hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.

India has received similar requests from several other countries including its immediate neighbours Sri Lanka and Nepal. India has said that it is reviewing its export ban order.

Notably, India's decision to ban the exports of hydroxychloroquine is driven by its desire to take stock of the domestic requirements and ensure that the country has enough of the drug.

"I would be surprised if he would, you know, because India does very well with the United States," Trump told reporters during a press briefing at the White House on Monday.

Trump and Modi enjoy a personal friendship as reflected in the president joining the prime minister at the "Howdy, Modi!" event in Houston last September.

This February, Trump made a rare India-specific solo trip to Ahmedabad and New Delhi.

India on Monday agreed to lift the ban on export of hydroxychloroquine to the US. Three Gujarat-based companies would export these tablets to the US, Chief Minister Vijay Rupani said on Tuesday.

India manufactures 70 per cent of the world's supply of hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA) secretary-general Sudarshan Jain.

The country has a production capacity of 40 tonnes of hydroxychloroquine (HCQ) every month, implying 20 crore tablets of 200 mg each. And since the drug is also used to auto-immune diseases like rheumatoid arthritis and lupus, manufacturers have good production capacities that can also be ramped up.

Tags: donald trump, coronavirus (covid-19), hydroxychrloroquine
ADVERTISEMENT
ADVERTISEMENT